These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 5539131)
21. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation. Chang P; Aronson DL; Borenstein DG; Kessler CM Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004 [TBL] [Abstract][Full Text] [Related]
22. Factor VIII physiology and pathology in man. Koutts J; Howard MA; Firkin BG Prog Hematol; 1979; 11():115-45. PubMed ID: 392590 [No Abstract] [Full Text] [Related]
23. The possibility of the recognition of carriers of hemophilia. Van Creveld S Bibl Haematol; 1966; 26():10-4. PubMed ID: 5957401 [No Abstract] [Full Text] [Related]
24. HEMOPHILIA IN A WOMAN. WHISSELL DY; HOAG MS; AGGELER PM; KROPATKIN M; GARNER E Am J Med; 1965 Jan; 38():119-29. PubMed ID: 14247283 [No Abstract] [Full Text] [Related]
26. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. Weinstein MJ; Chute LE J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875 [TBL] [Abstract][Full Text] [Related]
28. Characterization of procoagulants produced in cell cultures by tests of coagulation. Zacharski LR; McIntyre OR Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962 [No Abstract] [Full Text] [Related]
29. Physiologic considerations in the management of hemophilia. Briggs DK Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380 [No Abstract] [Full Text] [Related]
30. [Modification of plasma blood coagulation factor activity by physical stress]. Lutze G; Buhl H; Häcker R; Socha C; Socha U; Urbahn H Z Gesamte Inn Med; 1986 Sep; 41(18):502-5. PubMed ID: 3099480 [TBL] [Abstract][Full Text] [Related]
31. Clinical pattern of hemophilia and causes of variability. Mingot-Castellano ME Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S4-S6. PubMed ID: 31517708 [TBL] [Abstract][Full Text] [Related]
32. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity. Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013 [No Abstract] [Full Text] [Related]
35. [Studies on the consumption of blood coagulation factors in hemophilia]. Yasui T Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):627-39. PubMed ID: 5535817 [No Abstract] [Full Text] [Related]
36. Hemophilia: an updated review. Bell B; Canty D; Audet M Pediatr Rev; 1995 Aug; 16(8):290-8. PubMed ID: 7567698 [No Abstract] [Full Text] [Related]
37. Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells. Alipio Z; Adcock DM; Waner M; O TM; Fink LM; Ward DC; Ma Y Blood Coagul Fibrinolysis; 2010 Jul; 21(5):502-4. PubMed ID: 20595826 [No Abstract] [Full Text] [Related]
38. The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A. Daidone V; Galletta E; Bertomoro A; Casonato A Blood Transfus; 2018 Jan; 16(1):114-117. PubMed ID: 27893350 [No Abstract] [Full Text] [Related]
39. Familial association of thrombopathia and antihemophilic factor (AHF, factor VIII) deficiency. Crowell EB; Eisner EV Blood; 1972 Aug; 40(2):227-33. PubMed ID: 4537881 [No Abstract] [Full Text] [Related]
40. [The factor VIII complex: hemophilia A and von Willebrand disease]. Tobelem G; Rothschild C Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]